Reason for request
Renouvellement d'inscription
Clinical Benefit
| Moderate |
la Commission considère que le service médical rendu par CROMABAK 20 mg/ml, collyre en solution et CROMADOSES 2 %, collyre en solution en récipient unidose reste modéré dans l’indication de l’AMM.
|
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
wFtzLqQHNhYt2gLq